Trials / Completed
CompletedNCT02708485
Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's Disease
Evaluating the Impact of Physical Exercise on Mild Alzheimer's Disease in a Randomized Clinical Trial: Quantification With 18F -FDG and 11C- AcAc PET Imaging
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Université de Sherbrooke · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the effect of a 3-month walking program on brain energy metabolism in patient with mild Alzheimer's disease (AD). Two groups of sedentary patients with mild AD are followed and compared over a 3-month period of time: Control (non-active) and walking (from 15 to 45 minutes of exercise on a treadmill, 3 times a week for 12 weeks) groups. All the participants are evaluated on their cognition, brain volumes (MRI) and brain fuel consumption (PET scan with 18-FDG and 11C-AcAc) at the beginning and at the end of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Physical exercise | A 3-month walking program (3 times a week for 12 weeks) on treadmill supervised by a physiotherapist. Duration of the exercise is progressively increased from 15 min to 45 min over a 6-week period and the intensity of the exercise is moderate (a 12-13 score on Borg scale). |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2017-07-01
- Completion
- 2017-07-01
- First posted
- 2016-03-15
- Last updated
- 2018-10-16
- Results posted
- 2018-10-16
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02708485. Inclusion in this directory is not an endorsement.